Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAPTO: Haptoglobin and Vancomycin PK in aSAH
NCT06373640Not yet recruiting
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Nov 2024
- Primary completion
- Mar 2027
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
Randomised, open-label trial of vancomycin in aneurysmal subarachnoid hemorrhage (SAH) (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: CSF-haemoglobin concentration. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT06373640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06373640.